Authors

• Midas B. Mulder (ORCID: https://orcid.org/0000-0002-0925-3771)
• Dennis A. Hesselink (ORCID: https://orcid.org/0000-0003-1871-1962)
• Robert A. de Man (ORCID: https://orcid.org/0000-0002-1932-7412)
• Hans Blokzijl (ORCID: https://orcid.org/0000-0003-4240-7506)
• Laurence Roosens
• Maurice J. Ahsman (ORCID: https://orcid.org/0000-0002-6084-2571)
• Annemiek A. van der Eijk (ORCID: https://orcid.org/0000-0002-8918-5536)
• Joep de Bruijne
• Thomas Vanwolleghem (ORCID: https://orcid.org/0000-0002-0572-8741)
• Nassim Kamar (ORCID: https://orcid.org/0000-0003-1930-8964)
• Herold J. Metselaar (ORCID: https://orcid.org/0000-0002-7203-8126)
• Tamara J. van Steeg (ORCID: https://orcid.org/0000-0003-1387-1369)
• Brenda C. M. de Winter (ORCID: https://orcid.org/0000-0002-4452-8443)
• Marjolein Knoester (ORCID: https://orcid.org/0000-0002-4129-5234)
• Peggy Gandia (ORCID: https://orcid.org/0000-0002-4385-7894)
• Jacques Izopet
• Martijn van Noort

Institutions

• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• University Medical Center Groningen (NL)
• Université Toulouse III - Paul Sabatier (FR)
• University of Antwerp (BE)
• Inserm (FR)
• University of Groningen (NL)
• Erasmus MC (NL)
• University Medical Center Utrecht (NL)
• Antwerp University Hospital (BE)
• ERN GUARD-Heart (NL)
• Erasmus MC Cancer Institute (NL)
• ERN RARE-LIVER (DE)
• Erasmus University Rotterdam (NL)

Publication Details

Journal

Journal of Antimicrobial Chemotherapy

Published

2025-06-24

DOI

https://doi.org/10.1093/jac/dkaf183

Citations

2

Primary Topic

Hepatitis Viruses Studies and Epidemiology

Type

article

Field-Weighted Citation Impact

2.64

Funders

• Bristol-Myers Squibb
• Sanofi
• Sangamo Therapeutics
• Astellas Pharma
• Vifor Pharma
• Vlaamse regering
• Novartis Pharma